Wei Jing Jie-Tao Ma Cheng-Bo Han
10.3389/fonc.2020.00771
Front Oncol
2020 May 29;10:771.
egfr mutation her-2 amplification breast cancer lung metastasis molecular targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/32547945/
Case Reports
PMC7274020
32547945
Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report
2020